Turkey Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Learning HTML & CSS shouldn't be difficult. Master Trainer, Mark Lassoff, will teach you everything you need to know to create a creative and professional web site in 4 hours. From our sponsors

Turkey Pharmaceuticals and Healthcare Report Q1 2014 Nov 20th 2013, 00:00, by vyankatesh BMI View: Despite a challenging pricing and reimbursement situation, BMI still believes the market is attractive in the long term as higher y-o-y growth rates return from 2013/14. In contrast to European markets where manufacturers can expect to achieve higher prices, but with a stagnant growth outlook, Turkey offers strong growth potential if drugmakers are able to accept a price that is considerably below the European average and turn a profit on the low margins available. Headline Expenditure Projections ? Pharmaceuticals: TRY16.39bn (US$9.11bn) in 2012 to TRY17.16bn (US$8.89bn) in 2013; +4.7% in local currency and -2.4% US dollar terms. Local … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131680. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/turkey-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions